NEW YORK – T2 Biosystems reported after the close of the market on Tuesday that its second quarter revenues jumped 41 percent year over year.
For the three months ended June 30, the company posted revenues of $2.6 million compared to $1.8 million in Q2 2019, and beat the analysts' average estimate of $2.4 million. The results are within the preliminary earnings range that T2 issued on July 1.